Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026)

Zimmer Biomet Holdings (ZBH) recorded quarterly Income from Continuing Operations of 238300000.0 in Q1 2026, down 10.21% quarter-over-quarter from 265400000.0 in Q4 2025, and up 30.58% on a YoY basis from 182500000.0 in Q1 2025.

Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 238300000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 30.58% year-over-year to 238300000.0; the TTM figure through Mar 2026 stood at 888300000.0 (up 33.96% YoY), while the FY2025 annual figure was 832600000.0, up 27.43% from the prior year.
  • Income from Continuing Operations was 238300000.0 for Q1 2026 at Zimmer Biomet Holdings, down from 265400000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 419700000.0 in Q4 2023 to a low of 11700000.0 in Q4 2024.
  • Historically, Income from Continuing Operations has averaged 193111764.71 across 5 years, with a median of 194200000.0 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations sank 102.79% in 2024, then surged 2368.38% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 112200000.0 in 2022, then soared by 274.06% to 419700000.0 in 2023, then tumbled by 102.79% to 11700000.0 in 2024, then soared by 2368.38% to 265400000.0 in 2025, then decreased by 10.21% to 238300000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 238300000.0 (Q1 2026), 265400000.0 (Q4 2025), and 231200000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 220.30 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 238.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 238.30 Mn
Dec 31, 2025 265.40 Mn
Sep 30, 2025 231.20 Mn
Jun 30, 2025 153.40 Mn
Mar 31, 2025 182.50 Mn
Dec 31, 2024 -11.70 Mn
Sep 30, 2024 249.20 Mn
Jun 30, 2024 243.10 Mn
Mar 31, 2024 172.80 Mn
Dec 31, 2023 419.70 Mn
Sep 30, 2023 162.80 Mn
Jun 30, 2023 209.90 Mn
Mar 31, 2023 232.70 Mn
Dec 31, 2022 112.20 Mn
Sep 30, 2022 194.20 Mn
Jun 30, 2022 154.00 Mn
Mar 31, 2022 73.20 Mn
Dec 31, 2021 64.10 Mn
Sep 30, 2021 162.40 Mn
Jun 30, 2021 144.80 Mn